Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...
Kanter, Rosabeth Moss, Ai-Ling Jamila Malone, and Tessa Natanay Hamilton. "Advanced Leadership Pathways: Junko Yoda and Her Collaboration to Address Sex Trafficking in Asia." Harvard Business School ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果